Nemaura Medical is a Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT.
Nemaura Medical has raised $10.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in November 2023.
Nemaura Medical's investors include Chicago Venture Partners.
Nemaura Medical is headquartered in Loughborough, United Kingdom.
Nemaura Medical is a Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBEAT.
Nemaura Medical is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nemaura Medical — Funding & Investors." VCBacked, November 21, 2023, https://www.vcbacked.co/company/nemaura-medical. Accessed August 15, 2026.
VCBacked. (2023). Nemaura Medical — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/nemaura-medical
{{cite web |title=Nemaura Medical — Funding & Investors |url=https://www.vcbacked.co/company/nemaura-medical |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated